9:22 AM
Leo Group India
| ||
| Somaxon Pharmaceuticals to Raise $3.0 Million in Registered Direct Offering MarketWatch (press release) SAN DIEGO, Jul 20, 2012 (GlobeNewswire via COMTEX) -- Somaxon Pharmaceuticals, Inc. (NASDAQ:SOMX) , a specialty pharmaceutical company, today announced that it has entered into definitive agreements to sell approximately 9.4 million shares of its ... See all stories on this topic » | ||
| New pharmaceutical companies: Fed govt approves 32 licences PakTribune.com New pharmaceutical companies: Fed govt approves 32 licences. 20 July, 2012. ISLAMABAD: The federal government on Thursday approved 32 submissions for licensing to new pharmaceutical companies as well as fresh subjects of existing companies. See all stories on this topic » | ||
| Regeneron Pharmaceuticals - Aggressive Growth NASDAQ Shares of Regeneron Pharmaceuticals Inc. ( REGN ) have been on the upswing since the beginning of the year, primarily driven by strong sales of its eye drug Eylea. This biopharmaceutical stock, which is expected to release its second quarter 2012 results ... See all stories on this topic » | ||
| Ryan & Maniskas, LLP Announces Investigation of Par Pharmaceutical ... MarketWatch (press release) If you own shares of Par Pharmaceutical and would like to learn more about these claims or if you wish to discuss these matters and have any questions concerning this announcement or your rights, contact Richard A. Maniskas, Esquire toll-free at (877) ... See all stories on this topic » | ||
| Taro shareholders nix Sun offer to buy 33% Daily News & Analysis Minority shareholders of the NYSE-listed Israeli firm Taro Pharmaceuticals have turned down majority stakeholder Sun Pharmaceutical's $367 million offer to acquire the remaining one-third stake they do not own yet. Rejecting the proposal, they said in a ... See all stories on this topic » | ||
| Taro rejects Sun Pharma plan to buy remaining shares Hindu Business Line Taro has said that a special committee of its board of directors unanimously rejected the October 18, 2011, unsolicited, non-binding offer from Sun Pharmaceutical Industries Ltd. Sun and its affiliates had offered to purchase all of the issued and outstanding ... See all stories on this topic » | ||
| ||
| SUPERNUS PHARMACEUTICALS INC. : Supernus Appoints Dr. Stefan ... 4-traders ROCKVILLE, Md., July 20, 2012 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq:SUPN) today announced that Dr. Stefan Schwabe MD, PhD has joined the Company as Executive Vice President of Research and Development and Chief ... See all stories on this topic » | ||
| Healthcare Review: Anthera Pharmaceuticals Jumps, pSivida Corp and ... Reuters U.S. stocks extended gains on Thursday despite the fact that U.S. jobless claims jumped +34000 to 386000 last week. Several healthcare stocks are making notable moves at mid day:-. Anthera Pharmaceuticals Inc (NASDAQ:ANTH) shares plunged 14.29% ... See all stories on this topic » | ||
| Pharmaceutical manufacturer to open plant in Fort Lauderdale Sun-Sentinel BioRamo is a new company founded by pharmaceutical entrepreneur John Copanos, who owns Fort Lauderdale-based ECI Pharmaceuticals, which manufactures tablets and capsules. Copanos acquired Deltex Pharmaceuticals of Rosenberg, Texas, and is ... See all stories on this topic » |
Tip: Use quotes ("like this") around a set of words in your query to match them exactly. Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment